452 related articles for article (PubMed ID: 11592094)
21. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
[TBL] [Abstract][Full Text] [Related]
22. The p53 family member genes are involved in the Notch signal pathway.
Sasaki Y; Ishida S; Morimoto I; Yamashita T; Kojima T; Kihara C; Tanaka T; Imai K; Nakamura Y; Tokino T
J Biol Chem; 2002 Jan; 277(1):719-24. PubMed ID: 11641404
[TBL] [Abstract][Full Text] [Related]
23. Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
Papadogianni D; Soulitzis N; Delakas D; Spandidos DA
Tumour Biol; 2014 Mar; 35(3):2481-9. PubMed ID: 24213852
[TBL] [Abstract][Full Text] [Related]
24. p73 and p63: why do we still need them?
Blandino G; Dobbelstein M
Cell Cycle; 2004 Jul; 3(7):886-94. PubMed ID: 15254416
[TBL] [Abstract][Full Text] [Related]
25. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.
Boominathan L
Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462
[TBL] [Abstract][Full Text] [Related]
26. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
27. p63 and p73 transactivate differentiation gene promoters in human keratinocytes.
De Laurenzi V; Rossi A; Terrinoni A; Barcaroli D; Levrero M; Costanzo A; Knight RA; Guerrieri P; Melino G
Biochem Biophys Res Commun; 2000 Jun; 273(1):342-6. PubMed ID: 10873608
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.
Dietz S; Rother K; Bamberger C; Schmale H; Mössner J; Engeland K
FEBS Lett; 2002 Aug; 525(1-3):93-9. PubMed ID: 12163168
[TBL] [Abstract][Full Text] [Related]
29. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
[TBL] [Abstract][Full Text] [Related]
30. From p63 to p53 across p73.
Strano S; Rossi M; Fontemaggi G; Munarriz E; Soddu S; Sacchi A; Blandino G
FEBS Lett; 2001 Feb; 490(3):163-70. PubMed ID: 11223031
[TBL] [Abstract][Full Text] [Related]
31. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor.
Jung MS; Yun J; Chae HD; Kim JM; Kim SC; Choi TS; Shin DY
Oncogene; 2001 Sep; 20(41):5818-25. PubMed ID: 11593387
[TBL] [Abstract][Full Text] [Related]
32. The p53 family: same response, different signals?
Chen X
Mol Med Today; 1999 Sep; 5(9):387-92. PubMed ID: 10462750
[TBL] [Abstract][Full Text] [Related]
33. Structure, function and regulation of p63 and p73.
Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
[TBL] [Abstract][Full Text] [Related]
34. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.
Murray-Zmijewski F; Lane DP; Bourdon JC
Cell Death Differ; 2006 Jun; 13(6):962-72. PubMed ID: 16601753
[TBL] [Abstract][Full Text] [Related]
35. p53 Family isoforms.
Bourdon JC
Curr Pharm Biotechnol; 2007 Dec; 8(6):332-6. PubMed ID: 18289041
[TBL] [Abstract][Full Text] [Related]
36. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo.
Perez-Losada J; Wu D; DelRosario R; Balmain A; Mao JH
Oncogene; 2005 Aug; 24(35):5521-4. PubMed ID: 16007185
[TBL] [Abstract][Full Text] [Related]
37. A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma.
Ory B; Ramsey MR; Wilson C; Vadysirisack DD; Forster N; Rocco JW; Rothenberg SM; Ellisen LW
J Clin Invest; 2011 Feb; 121(2):809-20. PubMed ID: 21293058
[TBL] [Abstract][Full Text] [Related]
38. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas.
Chen YK; Huse SS; Lin LM
Clin Otolaryngol Allied Sci; 2003 Oct; 28(5):451-5. PubMed ID: 12969350
[TBL] [Abstract][Full Text] [Related]
39. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
[TBL] [Abstract][Full Text] [Related]
40. Expression profiles and functional implications of p53-like transcription factors in thymic epithelial cell subtypes.
Kikuchi T; Ichimiya S; Kojima T; Crisa L; Koshiba S; Tonooka A; Kondo N; Van Der Saag PT; Yokoyama S; Sato N
Int Immunol; 2004 Jun; 16(6):831-41. PubMed ID: 15126418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
